| Enhanced Bayesian modelling in BAPS software for learning genetic structures of populations J Corander, P Marttinen, J Sirén, J Tang BMC bioinformatics 9, 1-14, 2008 | 1001 | 2008 |
| Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans M Roberts, D Driggs, M Thorpe, J Gilbey, M Yeung, S Ursprung, ... Nature Machine Intelligence 3 (3), 199-217, 2021 | 968 | 2021 |
| Searching for drug synergy in complex dose–response landscapes using an interaction potency model B Yadav, K Wennerberg, T Aittokallio, J Tang Computational and structural biotechnology journal 13, 504-513, 2015 | 666 | 2015 |
| SynergyFinder: a web application for analyzing drug combination dose–response matrix data A Ianevski, L He, T Aittokallio, J Tang Bioinformatics 33 (15), 2413-2415, 2017 | 527 | 2017 |
| Toward more realistic drug–target interaction predictions T Pahikkala, A Airola, S Pietilä, S Shakyawar, A Szwajda, J Tang, ... Briefings in bioinformatics 16 (2), 325-337, 2015 | 473 | 2015 |
| Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis J Tang, A Szwajda, S Shakyawar, T Xu, P Hintsanen, K Wennerberg, ... Journal of Chemical Information and Modeling 54 (3), 735-743, 2014 | 447 | 2014 |
| Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products M Kibble, N Saarinen, J Tang, K Wennerberg, S Mäkelä, T Aittokallio Natural product reports 32 (8), 1249-1266, 2015 | 396 | 2015 |
| Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen MP Menden, D Wang, MJ Mason, B Szalai, KC Bulusu, Y Guan, T Yu, ... Nature communications 10 (1), 2674, 2019 | 324 | 2019 |
| Bayesian analysis of population structure based on linked molecular information J Corander, J Tang Mathematical biosciences 205 (1), 19-31, 2007 | 290 | 2007 |
| SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets S Zheng, W Wang, J Aldahdooh, A Malyutina, T Shadbahr, Z Tanoli, ... Genomics, Proteomics and Bioinformatics 20 (3), 587-596, 2022 | 287 | 2022 |
| Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans KH Pietiläinen, T Rog, T Seppänen-Laakso, S Virtue, P Gopalacharyulu, ... PLoS biology 9 (6), e1000623, 2011 | 283 | 2011 |
| Hyper-recombination, diversity, and antibiotic resistance in pneumococcus WP Hanage, C Fraser, J Tang, TR Connor, J Corander Science 324 (5933), 1454-1457, 2009 | 216 | 2009 |
| What is synergy? The Saariselkä agreement revisited J Tang, K Wennerberg, T Aittokallio Frontiers in pharmacology 6, 181, 2015 | 209 | 2015 |
| Methods for high-throughput drug combination screening and synergy scoring L He, E Kulesskiy, J Saarela, L Turunen, K Wennerberg, T Aittokallio, ... Cancer systems biology: methods and protocols, 351-398, 2018 | 201 | 2018 |
| Chloroplot: an online program for the versatile plotting of organelle genomes S Zheng, P Poczai, J Hyvönen, J Tang, A Amiryousefi Frontiers in genetics 11, 576124, 2020 | 195 | 2020 |
| DrugComb: an integrative cancer drug combination data portal B Zagidullin, J Aldahdooh, S Zheng, W Wang, Y Wang, J Saad, ... Nucleic acids research 47 (W1), W43-W51, 2019 | 185 | 2019 |
| Metabolome in schizophrenia and other psychotic disorders: a general population-based study M Orešič, J Tang, T Seppänen-Laakso, I Mattila, SE Saarni, SI Saarni, ... Genome medicine 3, 1-14, 2011 | 172 | 2011 |
| Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles J Tang, T Aittokallio Current pharmaceutical design 20 (1), 23-36, 2014 | 148 | 2014 |
| Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer A Malyutina, MM Majumder, W Wang, A Pessia, CA Heckman, J Tang PLoS computational biology 15 (5), e1006752, 2019 | 142 | 2019 |
| Drug target commons: a community effort to build a consensus knowledge base for drug-target interactions J Tang, B Ravikumar, Z Alam, A Rebane, M Vähä-Koskela, G Peddinti, ... Cell chemical biology 25 (2), 224-229. e2, 2018 | 133 | 2018 |
